Your stats are a tad dated - the FDA has far better (in terms of granularity) stats lately that show a pretty steady trend towards 'more approvals' in the past

Your stats are a tad dated - the FDA has far better (in terms of granularity) stats lately that show a pretty steady trend towards 'more approvals' in the past few years - this includes biosimilars and new molecular entities (novel drugs): https://www.fda.gov/downloads/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cder/ucm533192.pdf https://www.fda.gov/downloads/aboutfda/centersoffices/office...